Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany - results from the German AFNET registry.
about
Treating Specialty and Outcomes in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.Non-vitamin K-dependent oral anticoagulants have a positive impact on ischaemic stroke severity in patients with atrial fibrillation.Secondary prevention in non-valvular atrial fibrillation patients: a practical approach with edoxaban.Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Clinical Practice.Rivaroxaban in patients with atrial fibrillation: from ROCKET AF to everyday practice.
P2860
Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany - results from the German AFNET registry.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Use of vitamin K antagonists f ...... rom the German AFNET registry.
@ast
Use of vitamin K antagonists f ...... rom the German AFNET registry.
@en
type
label
Use of vitamin K antagonists f ...... rom the German AFNET registry.
@ast
Use of vitamin K antagonists f ...... rom the German AFNET registry.
@en
prefLabel
Use of vitamin K antagonists f ...... rom the German AFNET registry.
@ast
Use of vitamin K antagonists f ...... rom the German AFNET registry.
@en
P2093
P2860
P1433
P1476
Use of vitamin K antagonists f ...... rom the German AFNET registry.
@en
P2093
AFNET registry investigators
Andrea Gerth
András Treszl
Gerhard Steinbeck
Karl Georg Haeusler
Karl Wegscheider
Michael Nabauer
Michael Oeff
Thomas Meinertz
Tobias Limbourg
P2860
P2888
P356
10.1186/S12883-015-0371-8
P577
2015-08-05T00:00:00Z
P5875
P6179
1040654011